IPO Trending
HAMPSSME / BSEListed
Hamps Bio

Hamps Bio Limited, incorporated in 2007, is engaged in marketing and distributing pharmaceutical products under the “Hamps” brand and freeze-dried and frozen FMCG items under the “FzyEzy” brand. Its pharmaceutical portfolio includes tablets, syrups, capsules, injectables, and powders, distributed across eight Indian states and union territories through 50+ distributors and online platforms such as Amazon, Flipkart, and Jio Mart. The company’s FMCG division offers freeze-dried and frozen products like strawberry, mango, and beet powders for both B2B and B2C markets, including contract manufacturing. With a portfolio of 180+ products across both verticals, Hamps Bio serves domestic and international markets and employed 78 people as of October 31, 2024.

₹51 - ₹511050.21x sub
Listed Price₹96.90
Listing Gain+90.00%

Subscription Status

1050.21xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date13 Dec 2024
Close Date17 Dec 2024
Listing Date20 Dec 2024
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Hamps Bio IPO Subscription Demand

Live subscription status and bidding analysis for Hamps Bio (HAMPS) IPO. The issue is subscribed 1050.21x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions